AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Ocugen, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001TG1LS2
0.74▼ 0.05 (-6.37%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.79
Day's Range
0.73 – 0.80
52-Week Range
0.73 – 2.67
Volume
8.5M
Avg Volume
7.1M
Share Statistics
Shares Outstanding
Employees
116
Exchange
XNAS
Listed
2014-12-03
Share count as of July 31, 2026

Ocugen, Inc. Common Stock (OCGN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Ocugen, Inc. Common Stock (OCGN)
What is Ocugen, Inc. Common Stock's Market Cap?
Ocugen, Inc. Common Stock's Market Cap is $250.8M, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's Enterprise Value?
Ocugen, Inc. Common Stock's Enterprise Value is $152.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's Price / Sales?
Ocugen, Inc. Common Stock's Price / Sales is 54.8×, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's EV / Revenue?
Ocugen, Inc. Common Stock's EV / Revenue is 33.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's EV / EBITDA?
Ocugen, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's Revenue (TTM)?
Ocugen, Inc. Common Stock's Revenue (TTM) is $4.6M, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's Net Income (TTM)?
Ocugen, Inc. Common Stock's Net Income (TTM) is -$81.8M, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's EBITDA?
Ocugen, Inc. Common Stock's EBITDA is -$66.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's Diluted EPS (TTM)?
Ocugen, Inc. Common Stock's Diluted EPS (TTM) is -0.24, based on as-reported figures from SEC (XBRL) filings.
What is Ocugen, Inc. Common Stock's EBITDA Margin?
Ocugen, Inc. Common Stock's EBITDA Margin is -1451.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · OCGNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue—
YoY growth+8.4%—-125.3%+54.2%
Operating expenses
Research and development—
General and administrative—
Total operating expenses—
% of revenue1205.1%—-8705.7%1106.0%
Loss from operations—
% of revenue-1105.1%—8805.7%-1006.0%
Interest income—
Interest expense—
Loss on extinguishment of debt———
Change in fair value of derivative liability———
Other (expense) income, net—
Total other (expense) income—
Net loss
% of revenue-1671.8%—9174.1%-1144.5%
Net loss attributable to common shareholders — basic—
Net loss attributable to common shareholders — diluted—
Net loss per share attributable to shareholders - basic (in USD per share)—
Net loss per share attributable to shareholders - diluted (in USD per share)—